ABBVIE INC (ABBV) Stock Price, Quote, News and Overview
NYSE:ABBV - New York Stock Exchange, Inc. - US00287Y1091 - Common Stock
ABBV Quote and Key Statistics
ABBVIE INC
NYSE:ABBV (1/22/2025, 5:27:07 PM)
After market: 169.2 0 (0%)169.2
-3.41 (-1.98%)
ABBV Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.15% | ||
| ROA | 3.54% | ||
| ROE | 84.23% | ||
| Debt/Equity | 9.7 |
ABBV Performance and Technical Analysis
ABBV Ownership and Analysts
ABBV Latest News and Analysis
What's going on in today's session: S&P500 movers
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Wednesday as we examine the latest happenings in today's session.
Curious about the S&P500 stocks that are gapping on Wednesday? Explore the gap up and gap down stocks in the S&P500 index during today's session.
These S&P500 stocks are gapping in today's session
Got $1,500? 3 Healthcare Stocks to Buy and Hold Forever
Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why
The company expects to soon expand from a single-product player to a "multi-product innovator."
See Which Of The Latest 13F Filers Holds AbbVie
Got $500? 2 Pharmaceutical Stocks to Buy and Hold Forever
About ABBV
Company Profile
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Illinois and currently employs 50,000 full-time employees. The company went IPO on 2013-01-02. The company offers a comprehensive product portfolio across Immunology, Oncology, Neuroscience, Eye Care, Aesthetics, and Other Specialties. Immunology includes Rheumatology, Dermatology, and Gastroenterology. Oncology includes Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Diffuse large B-cell lymphoma, and others. Neuroscience includes Parkinson's disease, Migraine, Movement Disorders, Psychiatric Disorders, and Alzheimer’s disease. Eye Care includes Chronic Dry Eye Disease, Glaucoma, Age-Related Retinal Diseases, and Refractive Disorders. Aesthetics includes Botox Cosmetic, The Juvederm Collection of Fillers, and others. The company offers NX-13 for the treatment of ulcerative colitis (UC) and Crohn's disease (CD). The company also offers CEL383 for the treatment of inflammatory bowel disease.
Company Info
ABBVIE INC
1 N Waukegan Rd
North Chicago ILLINOIS 60064 US
CEO: Richard A. Gonzalez
Employees: 50000
Company Website: https://www.abbvie.com/
Investor Relations: https://investors.abbvie.com
Phone: 18479327900
ABBV Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| AMGN | AMGEN INC | 14.23 | 146.98B | ||
| GILD | GILEAD SCIENCES INC | 21 | 115.95B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 839.22 | 110.22B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.97 | 74.73B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.26B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 34.38B | ||
| BNTX | BIONTECH SE-ADR | N/A | 27.75B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.66B | ||
| NTRA | NATERA INC | N/A | 22.70B | ||
| BIIB | BIOGEN INC | 8.74 | 20.80B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.34B | ||
| UTHR | UNITED THERAPEUTICS CORP | 16.31 | 16.57B |